ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Tvardi Therapeutics Inc
25.21
-1.9000
-7.01%
盘后:
25.21
0.0000
0.00%
16:35 EDT
成交量:
5.10万
成交额:
130.58万
市值:
2.36亿
市盈率:
-1.62
高:
27.27
开:
27.03
低:
24.65
收:
27.11
数据加载中...
总览
公司
新闻
公告
BUZZ-Tvardi Therapeutics 在 Piper Sandler 开始报道后上涨
路透中文
·
06-13
Tvardi Therapeutics(TVRD.US)获奥本海默首次覆盖,给予优于大市评级, 目标价65.00美元。
金融界
·
05-21
BUZZ--美国股票走势-Xponential Fitness、Phillips 66、Amazon.com
路透中文
·
05-16
BUZZ--美国股票走势-沃尔玛、洛克希德-马丁公司、联合健康集团
路透中文
·
05-15
BUZZ-BTIG开始 "买入 "Tvardi公司,因其逆转肺部瘢痕的药物前景看好
路透中文
·
05-15
Tvardi Therapeutics Inc 预计每股亏损 35 美分 - 财报前瞻
路透中文
·
05-10
BUZZ-Cara Therapeutics 宣布反向拆股后股价上涨
路透中文
·
04-15
Cara Therapeutics, Inc.盘中异动 大幅上涨6.49%
市场透视
·
04-09
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TVRD/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVRD\",,,,,undefined,":{"symbol":"TVRD","market":"US","secType":"STK","nameCN":"Tvardi Therapeutics Inc","latestPrice":25.21,"timestamp":1750968000000,"preClose":27.11,"halted":0,"volume":51032,"hourTrading":{"tag":"盘后","latestPrice":25.21,"preClose":25.21,"latestTime":"16:35 EDT","volume":825,"amount":20792.49,"timestamp":1750970112497},"delay":0,"floatShares":7933194,"shares":9360904,"eps":-15.531682,"marketStatus":"未开盘","change":-1.9,"latestTime":"06-26 16:00:00 EDT","open":27.03,"high":27.27,"low":24.65,"amount":1305751.599376,"amplitude":0.096643,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.531682,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1751011200000},"marketStatusCode":0,"adr":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":27.11,"postHourTrading":{"tag":"盘后","latestPrice":25.21,"preClose":25.21,"latestTime":"16:35 EDT","volume":825,"amount":20792.49,"timestamp":1750970112497},"volumeRatio":0.344308},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVRD\",,,,,undefined,":{"symbol":"TVRD","floatShares":7933194,"roa":"--","roe":"--","lyrEps":-15.531682,"volumeRatio":0.344308,"shares":9360904,"dividePrice":0,"high":27.27,"amplitude":0.096643,"preClose":27.11,"low":24.65,"week52Low":8.1252,"pbRate":"--","week52High":34.31,"institutionHeld":0,"latestPrice":25.21,"eps":-15.531682,"divideRate":0,"volume":51032,"delay":0,"ttmEps":-15.531682,"open":27.03,"prevYearClose":18.36,"prevWeekClose":25.77,"prevMonthClose":28.34,"prevQuarterClose":15.21,"fiveDayClose":25.59,"twentyDayClose":30.86,"sixtyDayClose":15.21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVRD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543493945","title":"BUZZ-Tvardi Therapeutics 在 Piper Sandler 开始报道后上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2543493945","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543493945?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 01:01","pubTimestamp":1749747714,"startTime":"0","endTime":"0","summary":"BUZZ-Tvardi Therapeutics 在 Piper Sandler 开始报道后上涨6月12日 - ** Tvardi Therapeutics TVRD.O股价上涨4.5%至27.40美元 ** 派博-桑德勒启动了对TVRD的投资,给予 \"增持 \"评级,目标价78美元。** TTI-109 为 TVRD 提供了一个重要的管线机会,其优化的产品特性和扩展的覆盖范围可确保长期持续使用 - Piper Sandler ** 截至上次收盘,TVRD股价年累计上涨约43(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nL4S3SF17K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVRD","BK4007"],"gpt_icon":0},{"id":"2537932987","title":"Tvardi Therapeutics(TVRD.US)获奥本海默首次覆盖,给予优于大市评级, 目标价65.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537932987","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537932987?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 23:22","pubTimestamp":1747840948,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics(TVRD.US)获奥本海默首次覆盖,给予优于大市评级, 目标价65.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/21232250576773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","TVRD"],"gpt_icon":0},{"id":"2535087162","title":"BUZZ--美国股票走势-Xponential Fitness、Phillips 66、Amazon.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2535087162","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535087162?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 02:12","pubTimestamp":1747332753,"startTime":"0","endTime":"0","summary":"nL4N3RN0RZ ** Alibaba.com Ltd < BABA.N >:BUZZ - 因季度营收下滑而下跌 nL4N3RN0S6 ** Birkenstock Holding PLC < BIRK.N >:BUZZ - 因上调年度预期、提价计划抵消关税而上涨 nL4N3RN1AY ** Waystar Holding Corp < WAY.O >:BUZZ - 因大股东在 4.84 亿美元二次发行中减持股份而下跌 nL4N3RN0S9 ** Foot Locker Inc < FL.N >:BUZZ - 在迪克体育用品公司24亿美元的交易后迎来最好的一天。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL4T3RN1KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVX","ATRA","XOM","TOL","BHVN","CSIQ","ABT","BIRK","LMT","COP","DE","TTWO","ALL","LOAR","LU2362541513.USD","ELV","NFE","BK4201","AKAM","BK4559","LU2505996509.AUD","VIRT","BOOT","TVRD","USAW.SI","MOH","BK4568","SVV","DLO","AURA","KVYO","WAY","ISRG","XPOF","CVS","LU2077746001.SGD","BK4564","HUM","PSX","LU2756315318.SGD","LU1935043023.USD"],"gpt_icon":1},{"id":"2535342841","title":"BUZZ--美国股票走势-沃尔玛、洛克希德-马丁公司、联合健康集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2535342841","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535342841?lang=zh_cn&edition=fundamental","pubTime":"2025-05-15 19:36","pubTimestamp":1747308990,"startTime":"0","endTime":"0","summary":".N** Merck & Co Inc < MRK.N >:BUZZ - 财年展望下调后股价下跌。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL4S3RN0ZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRX11.SGD","DKS","CSIQ","LU0942090050.USD","SG9999014567.USD","BK4155","LU1815333072.USD","LU0683600562.USD","LOAR","KVYO","IE00B19Z9P08.USD","BK4548","XOM","LU0651947912.USD","BHVN","LU0175139822.USD","LU2362541273.HKD","WMT","LMT","SVV","LU0047713382.USD","LU2471134523.USD","LU1105468828.SGD","WAY","LU0211326755.USD","IE00BZ9MQY76.HKD","LU0861579265.USD","BIRK","UNH","BK4581","ALBmain","COP","IE00BKVL7J92.USD","IE00BSNM7G36.USD","CVX","LU0072462343.USD","TVRD","BK4592","CARA","LU1506573853.SGD","LU0466842654.USD","LU1983299246.USD","FL","LU0477156953.USD","LU0328353924.USD"],"gpt_icon":1},{"id":"2535219846","title":"BUZZ-BTIG开始 \"买入 \"Tvardi公司,因其逆转肺部瘢痕的药物前景看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2535219846","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535219846?lang=zh_cn&edition=fundamental","pubTime":"2025-05-15 19:18","pubTimestamp":1747307892,"startTime":"0","endTime":"0","summary":"BUZZ-BTIG开始 \"买入 \"Tvardi公司,因其逆转肺部瘢痕的药物前景看好5月15日 - ** BTIG开始对Tvardi Therapeutics TVRD.O进行评级,给予 \"买入 \"评级,目标价为55美元,较上一交易日收盘价上涨108.7%。** BTIG 表示,预计 25 年下半年即将公布的中期试验数据可能成为该股的主要催化剂 ** 截至上次收盘,该股今年累计上涨 43.5(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL4T3RN0YH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TVRD"],"gpt_icon":0},{"id":"2534609964","title":"Tvardi Therapeutics Inc 预计每股亏损 35 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2534609964","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534609964?lang=zh_cn&edition=fundamental","pubTime":"2025-05-10 08:15","pubTimestamp":1746836108,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics Inc 预计每股亏损 35 美分 - 财报前瞻Tvardi Therapeutics Inc TVRD.OQ TVRD.O预计在5月12日公布截至3月31日的财报时,。LSEG分析师对Tvardi Therapeutics Inc的平均预期是每股亏损35美分。华尔街对 Tvardi Therapeutics Inc 的 12 个月目标价中位数为 39.00 美元,高于其上次收盘价 25.61 美元。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250510:nL4T3RI00L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVRD"],"gpt_icon":0},{"id":"2527118418","title":"BUZZ-Cara Therapeutics 宣布反向拆股后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2527118418","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527118418?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 00:36","pubTimestamp":1744648564,"startTime":"0","endTime":"0","summary":"BUZZ-Cara Therapeutics 宣布反向拆股后股价上涨4月14日 - ** 生物制药公司 Cara Therapeutics CARA.O 股价上涨 14.5% 至 5.61 美元 ** Cara 表示 ,董事会已批准从 4 月 15 日起进行 1 对 3 的反向股票分割 ** 卡拉公司于 12 月与私人控股的 Tvardi Therapeutics 公司达成合并协议 ** 预计合并完成后,股票分割将以新名称 \"Tvardi Therapeutics Inc \"进行,股票代码为 \"TVRD\"。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL4T3QS1BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVRD","CARA","BK4007"],"gpt_icon":0},{"id":"2526848274","title":"Cara Therapeutics, Inc.盘中异动 大幅上涨6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526848274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526848274?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 00:23","pubTimestamp":1744129439,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日00时23分,Cara Therapeutics, Inc.股票出现波动,股价大幅拉升6.49%。Cara Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。Cara Therapeutics, Inc.公司简介:Cara Therapeutics Inc 是一家处于开发阶段的生物技术公司,致力于开发新型疗法来治疗与炎症、疼痛和瘙痒相关的人类疾病。Cara 的 CR845 旨在治疗急性疼痛和瘙痒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409002400aa2c62b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409002400aa2c62b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVRD","CARA","BK4007","BK4139","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"TVRD","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-3.22},{"market":"US","date":"2025-04-16","symbol":"TVRD","defaultRemindTime":1744810200000,"type":"split","dateTimestamp":1744776000000,"forFactor":3,"toFactor":1,"ratio":3},{"market":"US","date":"2025-03-11","symbol":"TVRD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-12-31","symbol":"TVRD","defaultRemindTime":1735655400000,"type":"split","dateTimestamp":1735621200000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2024-11-14","symbol":"TVRD","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1749787200000}}}